JW (CAYMAN) THERAPEUTICS CO. LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 2126 for the last semiannual is 94.07 M HKD, and it's 1.12% higher compared to the previous semiannual. The net income of H1 24 is -260.36 M HKD.